VENROCK ENTERPRENEURS FUND LP 4
4 · MEMORY PHARMACEUTICALS CORP · Filed Apr 12, 2004
Insider Transaction Report
Form 4Exit
VENROCK ENTERPRENEURS FUND LP
10% Owner
Transactions
- Conversion
Common Stock
[F1]2004-04-08+14,233→ 14,233 total - Conversion
Series C Convertible Preferred Stock
[F2][F3]2004-04-08−40,000→ 0 total→ Common Stock (14,233 underlying)
Footnotes (3)
- [F1]The shares of each Series of Preferred Stock were convertible into the number of shares of Common Stock indicated, and upon the closing of the Issuer's initial public offering of Common Stock, all such shares of Preferred Stock were automatically converted into the number of shares of Common Stock indicated.
- [F2]Upon the closing of the Issuer's initial public offering, each share of Series C Convertible Preferred Stock automatically converted into 0.3559 shares of the Issuer's Common Stock.
- [F3]Not applicable.
Signature
Anthony B. Evnin, Member of Venrock Management LLC, the General Partner of Venrock Entrepreneurs Fund, L.P.|2004-04-12